Related Experiment Video
Updated: Feb 23, 2026

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
Antidepressant use during pregnancy and psychiatric disorders in offspring: Danish nationwide register based cohort
Xiaoqin Liu1, Esben Agerbo2,3,4, Katja G Ingstrup2
1National Center for Register-based Research, Aarhus University, Aarhus, Denmark lxq@econ.au.dk.
Insights
In utero antidepressant exposure is linked to a higher risk of psychiatric disorders in children. This association may be influenced by maternal health conditions, not just the medication itself.
Area of Science:
- Perinatal psychiatry
- Developmental psychology
- Epidemiology
Background:
- Maternal antidepressant use during pregnancy is common.
- Understanding the long-term effects on offspring is crucial for informed clinical decisions.
- Previous studies have shown mixed results regarding the association between prenatal antidepressant exposure and child psychiatric disorders.
Purpose of the Study:
- To investigate the association between antidepressant exposure in utero and the risk of psychiatric disorders in children.
- To differentiate risks based on patterns of antidepressant use (continuation, discontinuation, new use).
- To explore potential confounding factors, such as maternal psychiatric disorder severity.
Main Methods:
- Population-based cohort study utilizing Danish national registers.
- Inclusion of over 900,000 liveborn singletons born between 1998 and 2012.
- Follow-up until July 2014 to ascertain first psychiatric diagnosis, with Cox regression models for hazard ratio estimation.
Main Results:
- Overall psychiatric disorder incidence was higher in children exposed to antidepressants in utero compared to unexposed.
- The highest incidence was observed in the 'new user' group (14.5%), followed by the 'continuation' group (13.6%).
- Antidepressant continuation during pregnancy showed a significantly increased risk (HR 1.27) compared to discontinuation.
Conclusions:
- In utero antidepressant exposure is associated with an elevated risk of psychiatric disorders in offspring.
- The observed association may be influenced by the severity of maternal psychiatric disorders, in addition to prenatal drug exposure.
- Future research should consider a broader spectrum of psychiatric outcomes and maternal factors.
Abstract:
Objective To investigate the association between in utero exposure to antidepressants and risk of psychiatric disorders.Design Population based cohort study.Setting Danish national registers.Participants 905 383 liveborn singletons born during 1998-2012 in Denmark and followed from birth until July 2014, death, emigration, or date of first psychiatric diagnosis, whichever came first. The children were followed for a maximum of 16.5 years and contributed 8.1×106 person years at risk.Exposures for observational studies Children were categorised into four groups according to maternal antidepressant use within two years before and during pregnancy: unexposed, antidepressant discontinuation (use before but not during pregnancy), antidepressant continuation (use both before and during pregnancy), and new user (use only during pregnancy).Main outcome measure First psychiatric diagnosis in children, defined as first day of inpatient or outpatient treatment for psychiatric disorders. Hazard ratios of psychiatric disorders were estimated using Cox regression models.Results Overall, psychiatric disorders were diagnosed in 32 400 children. The adjusted 15 year cumulative incidence of psychiatric disorders was 8.0% (95% confidence interval 7.9% to 8.2%) in the unexposed group, 11.5% (10.3% to 12.9%) in the antidepressant discontinuation group, 13.6% (11.3% to 16.3%) in the continuation group, and 14.5% (10.5% to 19.8%) in the new user group. The antidepressant continuation group had an increased risk of psychiatric disorders (hazard ratio 1.27, 1.17 to 1.38), compared with the discontinuation group.Conclusions In utero exposure to antidepressants was associated with increased risk of psychiatric disorders. The association may be attributable to the severity of underlying maternal disorders in combination with antidepressant exposure in utero. The findings suggest that focusing solely on a single psychiatric disorder among offspring in studies of in utero antidepressant exposure may be too restrictive.
Related Concept Videos
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Overview
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...

